AppYea

AppYea CapEx/OCF

Delisted·Sep 22, 2026

CapEx to Operating Cash Flow Ratio of AppYea (APYP) as of Oct 30, 2026.

CapEx/OCF

0.00

Last updated:

CapEx to Operating Cash Flow Ratio of AppYea is 2025 0.00 . CapEx to Operating Cash Flow Ratio of AppYea was 2024 -10.19 % . It decreases by % higher compared to the previous year.

The AppYea CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
-2.21 USD
Jan 1, 2019
-2.93 USD
Jan 1, 2020
-75.00 USD
Jan 1, 2021
-1.79 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
-15.58 USD
Jan 1, 2024
-10.19 USD
Jan 1, 2025
0.00 USD
The AppYea CapEx/OCF history
YEARCapEx/OCFYoY
0.00-100.00%
-10.19 %-34.58%
-15.58 %—
0.00-100.00%
-1.79 %-97.62%
-75.00 %+2,456.93%
-2.93 %+32.53%
-2.21 %—
0.00-100.00%
-24.62 %-66.19%
-72.83 %+675.54%
-9.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AppYea Stock analysis

What does AppYea do? AppYea Inc develops wearable monitoring solutions for sleep apnea and snoring treatment, focusing on the DreamIT wristband for snoring biofeedback and the DreamIT PRO wristband for sleep apnea treatment. The SleepX App monitors physiological parameters during sleep using algorithms developed by SleepX, while SleepX PRO is a medical application that identifies sleep apnea episodes without direct user contact. These products target patients seeking non-invasive sleep disorder management through wearable technology. The company's revenue streams come from direct sales of DreamIT, DreamIT PRO, and SleepX PRO to end-users, with the SleepX PRO app specifically positioned as a medical application for sleep apnea monitoring. The DreamIT and DreamIT PRO devices are sold alongside their respective apps, creating a bundled offering for consumers managing sleep-related health issues. The SleepX PRO app's medical certification enables it to be marketed as a healthcare solution rather than a general wellness tool. AppYea Inc's target market includes individuals diagnosed with sleep apnea or chronic snoring, who prefer wearable technology over traditional CPAP machines. The company positions its products as alternatives to conventional treatments, emphasizing convenience and non-invasive monitoring through the SleepX algorithms that process sensor data during sleep. Sales are driven by the medical application status of SleepX PRO, which differentiates it from consumer wellness apps. AppYea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AppYea stock

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio AppYea since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's AppYea with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — AppYea

All Key Metrics — AppYea